Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparative analyses of disease risk genes belonging to the acyl-CoA synthetase medium-chain (ACSM) family in human liver and cell lines.

Biochemical genetics - 1 Oct 2009

Boomgaarden Inka, Vock Christina, Klapper Maja, Döring Frank

Abstract excerpt

The human ACSM1, 2A and B, 3, and 5 genes, located on chromosome 16p12-13, encode for enzymes catalyzing the activation of medium-chain length fatty acids. Association studies have linked several polymorphisms of these genes to traits of insulin resistance syndrome. In our study, ACSM transcripts showed 3 to >400-fold higher expression levels in human liver when compared to cell lines by qRT-PCR. This difference...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Line
Share to Coenzyme A Ligases

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Enzymologic

Share to Genetic Predisposition to Disease

Share to Intracellular Space

Share to Protein Transport

Share to RNA, Messenger

Source

Identifiers

PMID: 19634011
DOI: 10.1007/s10528-009-9273-z

Genes

ACSM1
ACSM3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparative analyses of disease risk genes belonging to the acyl-CoA synthetase medium-chain (ACSM) family in human liver and cell lines.PMID 19634011Read ↗

Rapid, comprehensive screening of the human medium chain acyl-CoA dehydrogenase geneSemantic proximity Read ↗

Exploring Deleterious Nonsynonymous SNPs in the ACADM Gene: Insights Into Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD) via In Silico Analysis.Semantic proximity Read ↗

Role of long-chain acyl-CoA synthetases in MASH-driven hepatocellular carcinoma and ferroptosisSemantic proximity Read ↗

Inherent lipid metabolic dysfunction in glycogen storage disease IIIa.Semantic proximity Read ↗

Genetic Variation of Human Long-Chain Fatty Acyl-CoA Synthetase and Nutritional Implication.Semantic proximity Read ↗

Genetic Variation in the Mitochondrial Glycerol-3-Phosphate Acyltransferase Is Associated With Liver Injury.Semantic proximity Read ↗

ACSL5 genotype influence on fatty acid metabolism: a cellular, tissue, and whole-body study.Semantic proximity Read ↗

Analysis of gene mutations of medium-chain acyl-coenzyme a dehydrogenase deficiency (MCADD) by next-generation sequencing in Henan, China.Semantic proximity Read ↗

Acyl-CoA synthetase short-chain family member 2 (ACSS2) is regulated by SREBP-1 and plays a role in fatty acid synthesis in caprine mammary epithelial cells.Semantic proximity Read ↗

A comprehensive review of the family of very-long-chain fatty acid elongases: structure, function, and implications in physiology and pathologySemantic proximity Read ↗

Hepatic Tm6sf2 overexpression affects cellular ApoB-trafficking, plasma lipid levels, hepatic steatosis and atherosclerosis.Semantic proximity Read ↗

Mutations in the medium chain acyl-CoA dehydrogenase (MCAD) gene.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.